Synergistic effect of photothermal and magnetic hyperthermia for in situ activation of Fenton reaction in tumor microenvironment for chemodynamic therapy
Source abstract
Abstract
Traditional cancer treatments are ineffective and cause severe adverse effects. Thus, the development of chemodynamic therapy (CDT) has the potential for in situ catalysis of endogenous molecules into highly toxic species, which would then effectively destroy cancer cells. However, the shortage of high-performance nanomaterials hinders the broad clinical application of this approach. In present study, an effective therapeutic platform was developed using a simple hydrothermal method for the in-situ activation of the Fenton reaction within the tumor microenvironment (TME) to generate substantial quantities of •OH and ultimately destroy cancer cells, which could be further synergistically increased by photothermal therapy (PHT) and magnetic hyperthermia (MHT) aided by FeMoO4 nanorods (NRs). The produced FeMoO4 NRs were used as MHT/PHT and Fenton catalysts. The photothermal conversion efficiency of the FeMoO4 NRs was 31.75 %. In vitro and \ experiments demonstrated that the synergistic combination of MHT/PHT/CDT notably improved anticancer efficacy. This work reveals the significant efficacy of CDT aided by both photothermal and magnetic hyperthermia and offers a feasible strategy for the use of iron-based nanoparticles in the field of biomedical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (82)
Show source-provided references
1. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 202010.1002/cac2.12207 ↗
3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease10.1038/nrclinonc.2016.66 ↗
4. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer10.3816/CBC.2009.s.008 ↗
5. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement10.1016/j.nantod.2018.06.008 ↗
6. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
7. Delivering nanomedicine to solid tumors10.1038/nrclinonc.2010.139 ↗
8. Cancer nanomedicine: a review of recent success in drug delivery10.1186/s40169-017-0175-0 ↗
9. Photonic/magnetic hyperthermia-synergistic nanocatalytic cancer therapy enabled by zero-valence iron nanocatalysts10.1016/j.biomaterials.2019.119374 ↗
10. LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging10.1016/j.biomaterials.2015.07.055 ↗
11. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles10.1002/adma.201000260 ↗
12. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect10.1021/nn4017179 ↗
13. Gold-coated Fe3O4 nanoroses with five unique functions for cancer cell targeting, imaging, and therapy
14. Hyaluronic acid-modified Fe3O4 at au core/shell nanostars for multimodal imaging and photothermal therapy of tumors10.1016/j.biomaterials.2014.10.065 ↗
15. Synthesis and optimization of MoS2@Fe3O4-ICG/Pt(IV) nanoflowers for MR/IR/PA bioimaging and combined PTT/PDT/chemotherapy triggered by 808 nm laser10.1002/advs.201600540 ↗
16. Multifunctional Fe 3 O 4 @ polydopamine core À shell nanocomposites for intracellular mRNA detection10.1021/nn500722y ↗
17. Photo-electro active nanocomposite silk hydrogel for spatiotemporal controlled release of chemotherapeutics: an in vivo approach toward suppressing solid tumor growth10.1021/acsami.0c02470 ↗
18. A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy10.1016/j.biomaterials.2020.120079 ↗
19. A covalent organic framework derived N-doped carbon nanozyme as the all-rounder for targeted catalytic therapy and NIR-II photothermal therapy of cancer10.1021/acsami.3c09614 ↗
20. Fe3O4–Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment10.1039/C9NH00233B ↗
21. “All-in-one” nanoparticles for trimodality imaging-guided intracellular photo-magnetic hyperthermia therapy under intravenous administration10.1002/adfm.201705710 ↗
22. D-A-D structured selenadiazolesbenzothiadiazole-based near-infrared dye for enhanced photoacoustic imaging and photothermal cancer therapy10.1016/j.cclet.2021.02.017 ↗
23. Two-dimensional non-carbonaceous materials-enabled efficient photothermal cancer therapy10.1016/j.nantod.2016.05.009 ↗
24. Near-infrared inorganic nanomaterial-based nanosystems for photothermal therapy
25. Strategies to improve cancer photothermal therapy mediated by nanomaterials10.1002/adhm.201700073 ↗
26. Recent advances in MoS2-based photothermal therapy for cancer and infectious disease treatment10.1039/D0TB01018A ↗
27. Overview of the application of inorganic nanomaterials in cancer photothermal therapy10.1039/D0BM00222D ↗
28. Renal-clearable nickel-doped carbon dots with boosted photothermal conversion efficiency for multimodal imaging-guided cancer therapy in the second near-infrared biowindow10.1002/adfm.202100549 ↗
29. An enzyme-mimicking single-atom catalyst as an efficient multiple reactive oxygen and nitrogen species scavenger for sepsis management10.1002/anie.201912182 ↗
30. Molybdenum-based nanomaterials for photothermal cancer therapy10.1002/anbr.202200065 ↗
31. Smart acid-activatable self-assembly of black phosphorous as photosensitizer to overcome poor tumor retention in photothermal therapy
32. Near-infrared semiconducting polymer brush and pH/GSH-responsive polyoxometalate cluster hybrid platform for enhanced tumor-specific phototheranostics10.1002/anie.201808074 ↗
33. Ultrathin molybdenum carbide MXene with fast biodegradability for highly efficient theory-oriented photonic tumor hyperthermia10.1002/adfm.201901942 ↗
34. Dual-crosslinked dynamic hydrogel incorporating {Mo154} with pH and NIR responsiveness for chemo-photothermal therapy
35. “Double-punch” strategy against triple-negative breast cancer via a synergistic therapy of magneto-mechanical force enhancing NIR-II hypothermal ablation10.1016/j.biomaterials.2022.121868 ↗
36. Self-assembled quercetin-Fe3+ nanoparticles for synergetic near-infrared light-triggered low-temperature photothermal/glutathione-activated chemodynamic therapy10.1007/s40843-023-2536-1 ↗
37. Hollow mesoporous CeO2-based nanoenzymes fabrication for effective synergistic eradication of malignant breast cancer via photothermal–chemodynamic therapy10.3390/pharmaceutics14081717 ↗
38. Angiogenesis in cancer and other diseases10.1038/35025220 ↗
39. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
40. L.M. Coussens, Z. Werb, Inflammation and cancer.[J]. Pharm. Biotechnol., 2002, 420(6917)860., Nature. 420 (2002).10.1038/nature01322 ↗
41. H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay
42. Use of Fenton reagent to improve organic chemical biodegradability10.1016/S0043-1354(00)00342-0 ↗
43. Advanced oxidation processes for organic contaminant destruction based on the Fenton reaction and related chemistry10.1080/10643380500326564 ↗
44. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction
45. Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions10.1002/anie.201805664 ↗
46. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy10.1039/C7CS00471K ↗
47. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles10.1038/nnano.2007.260 ↗
48. Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes10.1038/s41596-018-0001-1 ↗
49. Near infrared-assisted Fenton reaction for tumor-specific and mitochondrial DNA-targeted photochemotherapy10.1016/j.biomaterials.2017.06.035 ↗
50. New evidence against hydroxyl radicals as reactive intermediates in the thermal and photochemically enhanced Fenton reactions10.1021/jp980129j ↗
51. FeMoO4 based, enzyme-free electrochemical biosensor for ultrasensitive detection of norepinephrine10.1016/j.bios.2016.03.029 ↗
52. Novel FeMoO4/graphene composites based electrode materials for supercapacitors10.1016/j.compscitech.2014.08.009 ↗
53. FeMoO4 nanorod array: a highly active 3D anode for water oxidation under alkaline conditions10.1039/C7QI00710H ↗
54. One-pot hydrothermal synthesis of FeMoO4 nanocubes as an anode material for lithium-ion batteries with excellent electrochemical performance10.1002/smll.201501294 ↗
55. Investigations on structural, optical and magnetic properties of solution-combustion-synthesized nanocrystalline iron molybdate10.1007/s12034-016-1339-z ↗
56. Efficient inhibition of photogenerated electron-hole recombination through persulfate activation and dual-pathway degradation of micropollutants over iron molybdate10.1016/j.apcatb.2019.117904 ↗
57. Silica-supported Fe-Mo-O catalysts for selective oxidation of propylene glycol10.1016/j.cattod.2018.07.029 ↗
58. Iron(II) molybdate (FeMoO4) nanorods as a high-performance anode for lithium ion batteries: structural and chemical evolution upon cycling
59. Novel approach for effective removal of methylene blue dye from water using fava bean peel waste10.1038/s41598-020-64727-5 ↗
60. Flower-like FeMoO4@1T-MoS2 micro-sphere for effectively cleaning binary dyes via photo-Fenton oxidation10.1016/j.jcis.2022.04.113 ↗
61. Hydrothermal synthesis and electrochemical performances of 1.7 V NiMoO4·xH2O||FeMoO4 aqueous hybrid supercapacitor10.1016/j.jcis.2014.04.010 ↗
62. Electroactive ultra-thin rgo-enriched FeMoO4 nanotubes and MnO2 nanorods as electrodes for high-performance all-solid-state asymmetric supercapacitors10.3390/nano10020289 ↗
63. Ternary Ti-Mo-Fe nanotubes as efficient photoanodes for solar-assisted water splitting10.1021/acs.jpcc.1c01478 ↗
64. Monodispersed plasmonic Prussian blue nanoparticles for zero-background SERS/MRI-guided phototherapy
65. Self-heating characteristics of cobalt ferrite nanoparticles for hyperthermia application10.1016/j.jmmm.2006.11.080 ↗
66. Ferrous disulfide-based photothermal nanocatalyst for NIR-II mild hyperthermia-enhanced chemodynamic therapy of temporal lobe epilepsy
67. Synthesis and magnetic property of FeMoO4 nanorods10.1016/j.mseb.2011.02.018 ↗
68. Induction of ferroptosis using functionalized iron-based nanoparticles for anti-cancer therapy
69. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles10.1038/s41598-020-68017-y ↗
70. Iron-based nanoparticles and their potential toxicity: focus on oxidative stress and apoptosis10.1016/j.cbi.2019.108935 ↗
71. ROS modulating inorganic nanoparticles: a novel cancer therapeutic tool
72. Cancer therapy with iron oxide nanoparticles: agents of thermal and immune therapies
73. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment
74. Biomedicine meets Fenton chemistry10.1021/acs.chemrev.0c00977 ↗
75. NIR responsive doxorubicin-loaded hollow copper ferrite @ polydopamine for synergistic chemodynamic/photothermal/chemo-therapy10.1002/smll.202205414 ↗
76. Role of quantitative analysis of T2 relaxation time in differentiating benign from malignant breast lesions10.1177/0300060517721071 ↗
77. T1- and T2-weighted magnetic resonance dual contrast by single core truncated cubic iron oxide nanoparticles with abrupt cellular internalization and immune evasion10.1021/acsabm.8b00016 ↗
78. The significant effect of size and concentrations of iron oxide nanoparticles on magnetic resonance imaging contrast enhancement10.1016/j.rinp.2019.102651 ↗
79. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
80. Synthesis of ultrasmall Fe3O4 nanoparticles as T1-T2 dual-modal magnetic resonance imaging contrast agents in rabbit hepatic tumors10.1021/acsanm.0c00306 ↗
81. Nanoparticles for MRI-guided radiation therapy: a review
82. Renal perfusion assessment using magnetic nanoparticles with 7T dynamic susceptibility contrast MRI in rats10.1016/j.jmmm.2018.11.041 ↗